⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DMAC News
DiaMedica Therapeutics Inc. Common Stock
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
businesswire.com
DMAC
DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
businesswire.com
DMAC
DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
businesswire.com
DMAC
DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025
businesswire.com
DMAC
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
DMAC
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences
businesswire.com
DMAC